September 22, 2014
Companies developing biotechnology products in a prefilled syringes are faced with a highly competitive market in leading therapeutic categories. As a result, all players have to implement new strategies to continuously improve their existing drug brands as part of lifecycle management or introduce new, superior products with better patient outcomes. At the same time, these manufacturers are challenged to reduce total unit cost, increase quality levels and ensure dose accuracy. Plungers play a key role in these new strategies and must be carefully selected especially with auto-injector drug delivery formats. Costly issues such as particle contamination, high levels of leachables forming during long term storage, and poor dose delivery performance can be avoided by selecting the right plunger product. In this presentation, attendees will learn about the latest plunger technology including Quality by Design options that address drug development challenges, quality risks and that optimize reliability of self injection devices in a highly competitive market.
Elastomer plungers are complex components and many times overlooked during selection of prefilled syringes especially when used in an auto-injector to deliver biologics. The intent of the presentation is to educate the audience on new technology options, user requirements that must be considered, and how to make the best plunger selection using a risk based approach.
Visit West at Booth #210 on October 6-7 to learn more.
West is a proud exhibitor at this event, and representatives will be on hands to demonstrate technologies and customer solutions for self-injection, administration, packaging systems and components. In addition to Tibor’s poster presentation, Graham Reynolds will present at the event:
- Global Market Trends – October 7, 4:00-5:30 p.m. Join Graham Reynolds, Vice President, Marketing and Innovation, West, as he moderates this session that will discuss the many factors which will drive and shape our industry in the coming years. Geographic expansion, increased access to healthcare, patient-centric solutions and the growth of biosimilars are examples of some of the topics to be explored.